Oxidative Dearomatization of Berbines for Therapeutic Efficacy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for more potent and efficacious berbine derivatives with therapeutic potential, particularly in antimicrobial, antidiabetic, and anticancer activities, as existing berbine compounds may have limitations in effectiveness.

Innovation Solution

The development of berbine derivatives with cyclohexadienone moieties through oxidative dearomatization, involving a process where a compound of Formula (VIIa) is contacted with an oxidizing agent to form a compound of Formula (VIIIa), using specific reaction conditions and reagents such as iodine or quinones, to enhance therapeutic properties.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If oxidative dearomatization is performed to create berbine derivatives with cyclohexadienone moieties, then therapeutic efficacy is improved, but reaction complexity increases

Engineering Contradiction:
Improvetherapeutic efficacyVSAvoidreaction complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies parameter changes by systematically varying reaction conditions including oxidizing agent selection (iodine, DDQ, other quinones), solvent types (alcohols, acetonitrile, dichloromethane), temperature ranges (-50°C to 200°C), and molar ratios of reactants to optimize the oxidative dearomatization reaction for producing therapeutically effective berbine derivatives while managing reaction complexity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses intermediary substances including various oxidizing agents (iodine, DDQ, quinones) and proton acceptors (acetate salts, bicarbonate salts, borate salts, carbonate salts, hydroxide salts, phosphate salts, butoxides, organic bases) that mediate the oxidative dearomatization reaction to transform berbines into derivatives with enhanced therapeutic properties

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If new berbine derivatives are developed to enhance therapeutic potential, then drug effectiveness is improved, but development time and resources increase

Engineering Contradiction:
Improvedrug effectivenessVSAvoiddevelopment time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent employs preliminary action by conducting systematic optimization of oxidative dearomatization reactions beforehand, establishing optimized protocols for oxidizing agents, solvents, temperatures, and molar ratios that can be directly applied to produce multiple berbine derivatives, thereby reducing development time for new therapeutically effective compounds

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The resulting berbine derivatives effectively inhibit cancer cell growth, offering improved therapeutic potential with potential applications in medicine.

Implementation Method 1

contacting a compound of Formula (Vila) with an oxidizing agent to form the compound of Formula (Villa)

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentEP3154968B1Oxidative dearomatization of berbines
Publication Date: 2020.08.05 SPECGX LLC
  • EP3154968B1 patent drawing
  • EP3154968B1 patent drawing
  • EP3154968B1 patent drawing

AI summary

The present disclosure provides oxidized berbine derivatives, processes for their preparation, and methods of using the oxidized berbine derivatives.